Experts probe safety concerns of anemia drugs. Panelists call for more restrictions.
Young
Donna
D
D000740:Anemia / Q000097:blood / Q000188:drug therapy*; D004921:Erythropoietin / Q000009:adverse effects; D005104:Expert Testimony; D006397:Hematinics / Q000009:adverse effects* / Q000592:standards; D006801:Humans; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin